Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
DHR.PRAは2022年4月14日に上場廃止となりました。
概要： In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
従業員数： 80,000
ニュース
DHR.PRAに関する最近のニュース記事はまだ届いていません。